Introduction vertebrate organisms Lehrer, 1994, 1995) . The ␣-defensins, which are found exclusively in mammals Study of the primary molecular and cellular defects re-(including humans), play a major role in host defense sponsible for cystic fibrosis (CF) lung disease has been at multiple sites, with the highest expression noted in complicated by the secondary abnormalities that result neutrophil granules and Paneth cells of the gut. ␤-defenfrom chronic respiratory infections. One hypothesis is sins have been described in a broader array of organthat ion transport abnormalities in the respiratory-conisms and sites. ducting epithelia lead to dehydration of mucus, inspissaZasloff and colleagues isolated the only known airway tion of secretions, and diminished clearance of inhaled epithelial defensins, tracheal antimicrobial peptide (TAP) pathogens (Welsh et al., 1995) . Another model is that and lingual antimicrobial peptide (LAP), which are memthe macromolecular composition of mucus in the CF bers of the ␤-defensin family. TAP was purified from airway is abnormal, affecting both its rheologic propercow trachea and shown to have bactericidal activity ties and affinity for microorganisms (Cheng et al., 1989;  against a broad array of organisms (Diamond et al., Tang et al., 1995; Pier et al., 1996) . A more recent hypoth-1991) . It is expressed at high levels in columnar epithelia esis suggests the primary event in pathogenesis is coloof the proximal conducting airway. A similar but distinct nization of the airway with pathogenic bacteria that initimolecule called LAP was isolated from cow tongue ate cycles of infection, inflammation, airway obstruction, (Schonwetter et al., 1995) . Genes encoding these pepand destruction of lung architecture. In this model, mutides are upregulated at a transcriptional level in recus represents the debris of chronic inflammation and sponse to bacterial LPS and inflammatory cytokines cell destruction composed of cellular DNA and cytoskelsuch as TNF␣ (Diamond et al., 1996; . etal proteins. Recent studies of CF infants who underActivation of LAP expression is observed in vivo at acwent bronchoscopy in the first months of life revealed tual sites of inflammation. These two molecules are not evidence of inflammation and bacterial colonization bestored in intracellular granules, which clearly distinfore onset of clinically overt disease (Armstrong et al.,
guishes them from known ␣-defensins.
The goal of this study was to define the molecular 1995, 1996) . basis of the antimicrobial activity in human ASF that is defective in CF.
Results

A Salt-Sensitive Bactericidal Activity Exists in ASF of Human Xenografts
To evaluate further the molecular basis of the defect in bacterial killing in CF ASF, we used an authentic model for CF lung biology based on the growth of human bronchial xenografts in nu/nu mice (Engelhardt et al., 1992b (Engelhardt et al., , 1993a Goldman et al., 1995; Zhang et al., 1996) . Primary cultures of epithelial cells derived from the proximal airways of CF and non-CF patients were seeded into denuded rat trachea and implanted subcutaneously into nu/nu mice with the proximal and distal ends open to the surface via ligated tubing. Within two weeks, a pseudostratified epithelium of human origin was established. Quantitative morphometric analysis of transmission electron micrographs indicated that the epithelium generated on the xenograft was indistinguishable in organization, cell type distribution, and ultrastructure when compared to the epithelium of the native bronchus from which the epithelial cells were derived (Engelhardt et al., 1992b (Engelhardt et al., , 1993a Zhang et al., 1996) . Submucosal glands containing ducts with serous and mucus tubules are partially formed (Engelhardt et al., 1995) . Previous studies evaluated the ion-conductive properties of the xenograft epithelia through the measurement of surface voltage in response to modulators of ion transport. In these studies, we showed functional properties of these epithelia were identical to those observed in the human nasal and intrapulmonary airways (Goldman et al., 1995) . The most discriminating measurement between non-CF the change in transepithelial potential difference in amiloride-treated epithelium in response to both chloride substitution and cAMP crobial assays and ion measurements by expelling the agonist treatment. As controls, non-CF (n ϭ 6) and CF xenografts luminal contents with air, followed by a brief centrifuga-(n ϭ 6) were treated with a recombinant adenovirus expressing tion to remove mucus. Direct ionic measurements of ␤-galactosidase. The ion measurements and antibacterial propernon-CF ASF revealed both the Na and Cl concentrations ties of ASF from grafts treated with the ␤-galactosidase vector were to be 83 Ϯ 3 mM. Antimicrobial activity was measured similar to untreated controls (data not shown).
by incubating ASF (30 l) with 10 3 P. aeruginosa for 2 hr at 37ЊC prior to a quantitative assessment of bacterial viability using standard colony counts. ASF from all non-
The relationship between ionic composition and bactericidal properties of ASF and the epithelial expression CF xenografts completely killed bacteria. This bacterial activity was inactivated in high salt and reducing agents, of CFTR was further studied in CF xenografts treated with adenoviral vectors containing a cDNA encoding and fractionated through gel filtration with an apparent molecular weight less than 10 (data not shown). Similar CFTR. E1-deleted adenoviral vectors expressing CFTR or ␤-galactosidase were instilled into the lumen of CF studies performed in CF xenografts revealed a significant increase in Na and Cl content in ASF to 178 Ϯ 9 xenografts. In situ hybridization revealed transduction and high-level recombinant CFTR expression in 9%-mM and 172 Ϯ 9 mM, respectively. ASF from all CF xenografts failed to kill P. aeruginosa. Diluting CF ASF in 15% of surface epithelial cells (Figure 2 ). CFTR gene transfer corrected the conductive properties of the CF hypotonic solution reconstituted the bactericidal activity (data not shown).
epithelia (⌬V T ϭ Ϫ12.7 Ϯ 0.3 in response to low chloride and cAMP) and normalized ASF Na (89 Ϯ 5 mM) and Cl signals, confirming the specificity of the assay ( Figure  4 , right column). (87 Ϯ 4 mM) (see Figure 1) . ASF from the CFTR-corrected CF xenografts was capable of complete killing of P.
To test the hypothesis that hBD-1 is a salt-sensitive antibiotic, a synthetic form of the mature peptide was aeruginosa in 10 out of 12 grafts, with partial killing in the remaining 2 (Figure 1 ). CF xenografts treated with made, retaining the three disulfide bridges (i.e., Cys 5 -Cys 34 , Cys 12 -Cys 27 , and Cys 17 -Cys 35 ). In the presence of similar doses of LacZ virus were indistinguishable from untreated grafts (data not shown).
low NaCl, synthetic hBD-1 demonstrated potent bactericidal activity to a broad array of organisms, including P. aeruginosa and E. coli ( Figure 5 and data not shown).
Human ␤-Defensin-1 Is a Salt-Sensitive Antibiotic Expressed in Human Airway
The impact of NaCl concentration on hBD-1 was evaluated by incubating the synthetic peptide with 5 ϫ 10 4
Previous studies by Bensch et al. (1995) identified a peptide in hemofiltrate of patients with end-stage renal colony-forming units of P. aeruginosa in the presence of varying NaCl concentrations ( Figure 5 ). The antimicrodisease that has structural similarities to previously described ␤-defensin peptides of other organisms. A parbial activity of hBD-1 exhibits a dramatic salt dependence characterized by a sharp loss of activity as the tial cDNA for this peptide was identified from mRNA isolated from kidney. Based on these modest sequence salt concentration increases from 50 mM to 125 mM. Bacterial killing was observed in low salt with concentrahomologies, they named the peptide human ␤-defensin-1 (hBD-1).
tions of hBD-1 varying between 60-500 g/ml. This titration of hBD-1 activity occurs in the range of NaCl that We cloned the full-length cDNA encoding hBD-1 from mRNA derived from cultured human bronchial epithelial distinguishes non-CF from CF ASF in native human proximal lung and the bronchial xenograft model. primary cells (Figure 3 ). This cDNA encodes an open reading frame of 68 amino acids in length with the characteristic features of a ␤-defensin, including a preproAntisense Inhibition of hBD-1 in Non-CF Bronchial Xenografts Ablates Antimicrobial peptide and six appropriately spaced cysteines. hBD-1 shows homology with the two previously described epiActivity in ASF Important to an understanding of CF lung pathogenesis thelial defensins from cow, i.e., TAP and LAP (Diamond et al., 1991; Schonwetter et al., 1995) .
is an identification of a molecule in ASF that confers microbial killing in non-CF lung and is inactive in CF. The homology of hBD-1 to TAP and its cloning from mRNA of a human airway cell-line suggested it may play
The tissue distribution of hBD-1 expression and its saltsensitivity to bacterial killing suggested it may play a a role in host defenses within human lung. Expression of hBD-1 was evaluated in tissue from human lung by role in ASF-mediated host defense. In situ hybridization demonstrated high-level and diffuse hBD-1 expression in situ hybridization. Figure 4 presents a series of micrographs of non-CF and CF lung tissues hybridized to in epithelia from both non-CF (Figures 4M-4O) and CF (Figures 4P-4R) xenografts that was indistinguishable antisense and sense probes of hBD-1. High-level RNA for hBD-1 was present throughout the superficial confrom native tissue. The role of hBD-1 in microbial killing was further studied by genetically ablating its expresducting airway of non-CF lung from proximal bronchi ( Figures 4A-4C ) through distal bronchioles (Figures 4D-sion with a 21-mer phosphorothioate oligonucleotide antisense DNA specific to the 5Ј region of mRNA that 4F). Expression was also detected throughout the epithelia of submucosal glands ( Figures 4A and 4B ) and encodes hBD-1. Controls included 1 nonsense oligonucleotide containing a scrambled sequence and 2 misalveolar cells (Figures 4D and 4E ). This differs from the expression of TAP in bovine lung that was primarily matched oligonucleotides identical to the antisense oligo at 19 of 21 (mismatch 1) and 14 of 21 (mismatch detected in proximal airway (Diamond et al., 1991) . A similar distribution of hBD-1 expression was demon-2) nucleotides. The oligonucleotides were instilled into the lumen of non-CF xenografts, and three days later strated in the CF lung (proximal airway, Figures 4G-4I; distal airway, Figures 4J-4L) . Hybridization of serial sec-ASF was harvested for microbial killing assays ( Figure  6A ) prior to removal of the xenografts for isolation of tions with the sense probe failed to demonstrate specific , 1995) . Analysis of synthetic hBD-1 in our study confirmed that it 6B). RNA for hBD-1 was detected by RT-PCR at equivalent levels in all non-CF xenografts that were either unhas broad-spectrum antimicrobial activity against gramnegative organisms (i.e., P. aeruginosa and E. coli) at treated or preincubated with nonsense, mismatch 1, or mismatch 2 oligonucleotides. Preincubation of non-CF concentrations similar to what has been described for most classical defensins (i.e., 10-100 g/ml; Ganz and xenografts with these control nucleotides had no effect on the ASF antimicrobial activity; eight out of nine ASF . hBD-1 showed structural homology with the bovine ␤-defensin TAP, although its distribution of samples completely killed bacteria while one sample yielded only 20 colonies. Preincubation of non-CF xenoexpression within human lung is different (Diamond et al., 1991) . The gene encoding hBD-1 is diffusely exgrafts with the hBD-1 antisense oligonucleotide substantially diminished RNA for hBD-1 in six out of eight pressed at high levels throughout the conducting and respiratory airway from the mainstem bronchus to alvexenografts, each of which failed to completely kill bacteria; full antimicrobial activity was retained in two antioli, including the epithelia of the submucosal glands, whereas expression of the TAP gene is restricted to sense-treated xenografts that were the same grafts in which the RNA for hBD-1 was not decreased.
proximal superficial epithelia. Several observations support the hypothesis that hBD-1 is involved in innate immunity in the lung and Discussion that its activity is compromised in CF. The gene encoding hBD-1 is expressed at high levels in most surface Chronic respiratory infections with pathogens such as P. aeruginosa and S. aureus characterize the pulmonary epithelial cells throughout the lung. Secretion of hBD-1 into the airway lumen would lead to wide distribution manifestations of CF (Welsh et al., 1995) . One explanation for this aspect of the disease was recently of highly concentrated antibiotic peptide in ASF, the volume of distribution of which has been estimated to suggested by Smith et al. (1996) , who demonstrated a salt-sensitive antimicrobial activity in the ASF of nonbe no greater than 8-10 ml spread over 2 m 2 of airway surface (Boucher, 1994) . In addition, the impact of NaCl CF-cultured cells that was defective in CF. We describe in this study the characterization of a novel antimicrobial on hBD-1 function correlates with the NaCl-dependent antimicrobial activity in ASF measured by Smith et al. peptide, called human ␤-defensin-1 (hBD-1), which is expressed in human airway epithelial cells and confers (1996) and in our xenograft model. Furthermore, the change in NaCl that occurs in ASF of native lung as a salt-dependent antimicrobial activity in ASF.
hBD-1, isolated from hemodialysate of humans with result of CFTR deficiency (i.e., 80 mM NaCl in non-CF versus 120-170 mM in CF [Gilljam et al., 1989 ; Joris et end-stage renal failure, was classified as a ␤-defensin antimicrobial peptide based on sequence homology to al., 1993]) spans the range of NaCl that inactivates hBD-1 Figure 5 . The Activity of hBD-1 Peptide Is Salt Dependent Synthetic hBD-1 was incubated with 5 ϫ 10 4 colony-forming units of P. aeruginosa in 100 l of 10 mM phosphate buffer (pH 7.4) and the indicated concentrations of NaCl. Reactions were then incubated at 37ЊC for 20 min. Serial dilutions were plated and colony counts performed the following day. Similar bacterial killing in low NaCl solution was observed with hBD-1 concentrations ranging from 60 to 500 g/ml.
Our data suggest that the bactericidal activity in human airway to some gram-negative organisms is primarily constituted through the action of a single antimicrobial peptide, hBD-1. This is interesting in that many defensins exist as families of genes whose products serve complementary and sometimes redundant functions, although this type of genetic program differs substantially between species. For example, there are four ␣-defensins in human polymorphonuclear neutrophils Lehrer, 1994, 1995) , whereas no ␣-defensin Pulmonary Tissues protein has been identified in murine polymorphonuclear Antisense (middle column) and sense (right column) oligonucleoneutrophils (Eisenhauer and Lehrer, 1992) . The enteric tides to the gene encoding hBD-1 were probed to sections of human defensins exist as a family of up to 16 genes in the mouse lung tissues and were exposed to photoemulsion for six days. Proximal (A-C and G-I) and distal noncartilagenous airways (D-F and (Ouellette et al., 1989; Huttner et al., 1994) , whereas only Bevins, 1992, 1993; Mallow et al., 1996) . xenografts (P-R) are also shown (bottom rows). Bright-field (left While our data suggest a primary role for hBD-1 in lung column) and dark-field (middle column) photomicrographs of the against some bacterial pathogens, they do not rule out same region are presented. mRNA encoding hBD-1 was not seen a role for other antimicrobial substances in the lung.
in serial sections hybridized with the antisense probe after treatment of the section with RNase, confirming the specificity of the assay.
The fact that antisense inhibition of hBD-1 does not
Arrowheads indicate epithelium; stars denote submucosal glands.
fully prevent microbial killing is consistent with either Magnification: proximal airway, 8ϫ; distal airway and xenografts, incomplete inhibition of hBD-1 or the existence of other 12.5ϫ. bactericidal molecules. Furthermore, other defensins with complementary functions may play a more significant role against fungal, viral, and other bacterial (i.e., from 50-125 mM). In fact, hBD-1 is partially inactipathogens. vated at the NaCl concentration of non-CF ASF, sug-
The question remains as to the contribution of hBD-1 gesting that any perturbation in ASF NaCl concentration inactivation to the pathogenesis of CF. Its role in the will have a direct effect on hBD-1 function. The most development of disease in extrapulmonary organs such compelling evidence for the role of hBD-1 in CF lung as liver, pancreas, and the male reproductive tract is pathogenesis was provided in antisense experiments, not obvious, since infection does not routinely occur at where specific ablation of hBD-1 function in non-CF these sites. The story in lung is substantially different, xenografts abolished bactericidal activity in ASF. The where colonization with bacterial pathogens and indices specificity of this assay was illustrated in control experiof chronic infection are established in the first four ments in which mismatches in only 2 of 21 nucleotides months of life in what appears to be an otherwise normal of the antisense oligonucleotide failed to inhibit hBD-1 pulmonary system (Armstrong et al., 1995 (Armstrong et al., , 1996 . The hypothesis that emerges from this work is that a breach activity.
in the proximal duct. In the CF sweat gland, Cl absorption is defective, thus leading to elevated NaCl in sweat (Quinton, 1983) . In extending this model to lung, it will be important to identify the site(s) of CFTR-independent Cl secretion into the airway. One possibility is the submucosal glands, which express high levels of CFTR and have substantial secretory capacity (Engelhardt et al., 1992a) . Finally, it will be important to reconcile the elevated NaCl in CF ASF with the finding of sodium hyperabsorption that characterizes the CF defect in polarized epithelia (Willumsen and Boucher, 1991; Goldman et al., 1995) .
The putative role of hBD-1 in lung pathogenesis of CF has implications in the development of therapy. This model supports the rationale for gene therapy in which reconstitution of CFTR function normalizes the ionic milieu of the ASF. Indeed, we show in the xenograft model that as little as ‫%01ف‬ gene transfer leads to a diminution tive chloride channels should be useful if ASF NaCl is Antibacterial activity was uniformly present in the ASF from all grafts before the administration of any oligonucleotide (data not shown).
corrected. Pharmacologic administration of ␤-defensin
Antibacterial broth assays were performed against P. aeruginosa into the airway would be therapeutic only if a salt-insen- The structure, production, and measurement of titer of E1-deleted tides. Four days after the local administration of the oligonucleotide, viruses that express ␤-galactosidase (CMV promoter in a sub360 grafts were explanted and RNA isolated. RT-PCR was performed backbone) and CFTR (CMV-enhanced ␤-actin promoter in a dl7001 using hBD-1 or ␤1-integrin subunit-specific primers, and an aliquot backbone) have been described previously (Engelhardt et al., of the reaction mixture blotted to a nitrocellulose membrane and 1993b). The viruses were titred as previously described (Engelhardt hybridized with specific probes. et al., 1993b) .
Generation of Bronchial Xenografts
in innate immunity occurs due to the inactivation of Human bronchial tissues were obtained from explanted or donor hBD-1 in the high salt environment of the CF ASF, which lungs at the time of lung transplantation, and bronchial xenografts leads to colonization in the airway with microbial pathowere prepared as previously described (Engelhardt et al., 1992b (Engelhardt et al., , 1993a Goldman et al., 1995) . Surface epithelial cells were removed gens and chronic pulmonary inflammation. Other comby incubating the bronchus in protease 14 (Sigma), plated in primary ponents of innate immunity and antigen-specific immuculture, and maintained for 5-7 days prior to release with trypsin.
nity are mobilized without apparent success in clearing Donor rat tracheas were harvested from CO2-asphyxiated Fisher of bacteria. Major components of the mucus within the 344 rats (200 g), from which the epithelium was denuded by three airway are derived from debris of the ongoing inflammarounds of freeze thawing. These tracheas were ligated to tubing at tory process, including DNA and cytoskeletal proteins of both ends after seeding of 2 ϫ 10 6 primary bronchial epithelial cells in 30 l of hormonally defined growth medium (Clonetics). Grafts inflammatory cells. Pharmacologic agents that dissipate were then implanted subcutaneously in the flanks of male nu/nu the secondary components of mucus, such as DNase BALB/c mice and maintained for three weeks in vivo to allow for for DNA and gelsolin for actin, are in fact being evaluated maturation of a fully differentiated bronchial epithelium. Virus was for treatment of the obstructive components of CF lung instilled into the graft lumen (5 ϫ 10 10 pfu/ml, 100 l) and expelled disease (Fuchs et al., 1994; Vasconcellos et al., 1994) .
with air 6 hr later. Samples from three CF lungs (⌬F508 homozygotes)
One issue not resolved is whether primary defects in and six non-CF lungs were used to generate xenografts for these studies.
mucus biochemistry and rheology also contribute to obstructive lung disease and infection.
Transepithelial Potential Difference Measurements
Further consideration of this model will require a betXenografts were analyzed for changes in potential difference (PD) ter understanding of the perturbations in ion and water in response to perfusion with different solutions before and after transport that occur at the airway surface in CF. Quantigene transfer as described previously (Goldman et al., 1995) . In tative measures of electrolytes in ASF are difficult, alpreparation for these measurements, animals were anesthetized with intraperitoneally administered ketamine/xylazine (100 l, 10%
though there has been a consistent trend toward elev/v) in phosphate-buffered saline (PBS) (pH 7.4). Agar bridges were vated NaCl in CF in a variety of models, including in vitro prepared by filling 21-gauge butterfly needles and tubing with 1 M cultures (Smith et al., 1996) , human bronchial xenografts KCl in 4% agar. The reference bridge was implanted subcutaneously (this study), and native human airway (Gilljam et al., in the flank of the mouse while the exploring electrode bridge was 1989; Joris et al., 1993) . It is possible the human airway in contact with a reservoir of buffered solution being delivered at a exhibits a functional similarity to the sweat gland, where constant rate of 2 ml/min by a syringe pump. Each bridge was connected by a calomel half-cell to a voltmeter. Measurements were
Cl is secreted in the lumen in the distal coil and absorbed recorded every 10 s by a computer interfaced with the voltmeter. was transferred to fresh LB and incubated for an additional 2-3 hr at 37ЊC to obtain mid-logarithmic-phase cells. The organisms were Prior to their use, pairs of agar bridges were kept in a common reservoir of buffered solution and only the electrodes that differed washed with 10 mM sodium phosphate buffer (pH 7.4), and the concentration of colony-forming units (CFU) per ml Ϫ1 quantitated less than 0.2 mV were used for analysis. Each recording measured voltage as a function of time in response to the sequential perfusion by measuring its absorbance at 620 nm. ASF (30 l) was mixed with 10 3 bacterial CFU and incubated for 2 hr at 37ЊC. Serial dilutions of the following: (i) HEPES phosphate-buffered ringers solution (HPBR) containing 10 mM HEPES (pH 7.4), 140 mM NaCl, 5 mM were then plated and colony counts completed the following day. Analyses of airway surface fluid were conducted from at least 12 KCl, 1.2 mM MgSO 4, 1.2 mM Ca gluconate, 2.4 mM K2HPO4, and 0.4 mM KH 2PO4; (ii) HPBR with 100 M amiloride; (iii) chloride-free individual non-CF and CF xenografts, before and after gene transfer. Identical studies were also performed on six non-CF xenografts HPBR (gluconate replaces chloride) with 100 M amiloride; (iv) chloride-free HPBR with 100 M amiloride, 200 M 8-cpt cAMP, and treated with a recombinant adenovirus expressing ␤-galactosidase. 100 M forskolin; and (v) return to HPBR.
Peptide Synthesis Isolation of the cDNA Encoding hBD-1
A peptide corresponding to the mature form of hBD-1 was syntheThe cDNA encoding hBD-1 was amplified from primary human bronsized by the solid phase methodology. The regioselective formation chial epithelial cell poly(A) ϩ RNA by 5Ј and 3Ј RACE (Frohman et al., of the three disulfide bridges, Cys 5 -Cys 34 (I), Cys 12 -Cys 27 (II), and 1988). The primers used were derived from the nucleotide sequence Cys 17 -Cys 35 (III), was carried out following published procedures of hBD-1 (Bensch et al., 1995) . Amplification products were sub- (Kellenberger et al., 1995) . The disulfide bridge I was formed first, cloned into a Bluescript vector (Stratagene) and sequenced. Multiple followed by the disulfide bridges II and III. The peptide was characclones were analyzed to verify the nucleotide sequence, and a fullterized by mass spectral high performance liquid chromatographic length cDNA was reconstructed.
and capillary zone electrophoretic analyses. A detailed discussion of the synthesis, purification, and characterization of this molecule will be published elsewhere.
In Situ Analyses
To perform cytochemical analyses, the xenografts were explanted, embedded in OCT (Tissue-TCK, Miles Inc.), and cryosectioned. TisOligonucleotide Delivery to Xenografts sue sections (6 m) were mounted on slides and fixed in 4% paraand Molecular Analysis formaldehyde in PBS (pH 7.4) for 4 hr. Following fixation, sections Phosphorothioate oligonucleotides consisted of 21-mer analogs to were dehydrated through graded concentrations of ethanol. Secthe 5Ј end of the hBD-1 gene. Mismatches are underlined. Antisense tions were then desiccated overnight under vacuum and stored 5Ј-CAGAAGGTAGGAAGTTCTCAT-3Ј, nonsense 5Ј-TACAGAGGTG at Ϫ20ЊC. The following day, sections were treated with 10 g/ml CTCACTGGGTA-3Ј, mismatched 1 5Ј-CAGAAGGTAGGAAGTTGT proteinase K for 30 min at 30ЊC, rinsed twice in 0.2ϫ SSC for 30 s CTT-3Ј, and mismatched 2 5Ј-TCTAAGGTAGGGAGTTCTTTG-3Ј each time, fixed in 4% paraformaldehyde in PBS, rinsed twice in phosphorothioate oligonucleotides were instilled into non-CF xeno-0.1 M triethanolamine (pH 8.0) for 4 min each time, incubated in grafts at a concentration of 20 M oligonucleotide in 70 M phos-0.25% acetic anhydride for 10 min at room temperature, and then phate buffer (pH 7.4). Any remaining solution was expelled with air dehydrated through graded concentrations of ethanol. Sections the following day. The ability of ASF to kill bacteria was measured were again dried under vacuum before prehybridization for 4 hr at before and then three days after oligonucleotide delivery. Antibacte-54ЊC in 10 mM Tris (pH 8.0), 50% formamide, 2.5ϫ Denhardt's, 0.6M rial broth assays were performed as previously described. Grafts NaCl, 1 mM EDTA (pH 8.0), 0.1% SDS, 500 g/ml tRNA, and 10 mM were harvested four days after oligonucleotide administration and dithiothreitol (DTT). RNase control sections were treated with 200 total RNA was prepared using RNAzol B (Tel-Test, Inc). RT-PCR g/ml RNase A for 1 hr at 37ЊC before the prehybridization step.
was performed on 1 g of template RNA using the Titan RT-PCR Sections were then hybridized with 5 ϫ 10 6 cpm/ml 35 S antisense system (Boehringer Mannheim) and primer sets specific for hBD-1 or sense probes for 16 hr at 54ЊC. Probes were synthesized with or ␤1-integrin subunit. Aliquots of the PCR reactions were resolved the Promega in vitro transcription system using 35 S UTP and 35 S on a 1% agarose gel, blotted to nitrocellulose, and hybridized to CTP. cRNA probes for hBD-1 were generated from the T7 and T3 specific 32 P random primer-labeled probes. The cDNA for the human RNA polymerase promoters of full-length cDNA encoding hBD-1 ␤1-integrin subunit was kindly provided by Dr. Clayton Buck (The and were subcloned into BlueScript (Stratagene). Probes for CFTR Wistar Institute, Philadelphia, PA). were synthesized from the T7 and SP6 RNA polymerase promoters of a PCR template derived from the cDNA for CFTR. Following Acknowledgments hybridization, slides were washed in 4ϫ SSC for 20 min (four changes) at room temperature, RNase (20 g/ml) for 30 min at 37ЊC, Technical support from Dr. Po-Shun Lee and the contributions of 2ϫ SSC/1 mM DTT at room temperature for 10 min (two changes), the Cell Morphology Core of the Institute for Human Gene Therapy and finally, three 15 min washes in 0.5ϫ SSC/1 mM DTT at 54ЊC.
were greatly appreciated. We are also grateful for technical support Slides were dehydrated through ethanol and air dried before dipping provided by Suja Rani and Sharon Klepfer of Magainin Pharmaceutiin photoemulsion (Kodak). Slides were developed and analyzed by cals. NIDDK and NHLBI of the NIH, the Cystic Fibrosis Foundation, bright-and dark-field microscopy using a Microphot-FXA Nikon and Genovo Inc. (a company that J. M. W. founded and holds equity microscope. The efficiency of adenovirus-mediated CFTR gene in) provided financial support. transfer to xenografts was determined by dividing the number of positive signals by the total number of cells present in 20 sections Received December 30, 1996; revised January 22, 1997. derived from multiple blocks of each treated graft. Expression of hBD-1 was evaluated in xenografts from uninfected samples. References Analyses of ASF from Non-CF and CF Xenografts Armstrong, D.S., Grimwood, K., Carzino, R., Carlin, J.B., Olinsky, A., To obtain sufficient volumes of ASF for study, airway secretions in and Phelan, P.D. (1995) . Lower respiratory infection and inflammaxenografts were allowed to accumulate for at least one week and tion in infants with newly diagnosed cystic fibrosis. Br. Med. J. 310, then collected by expulsion with air. After a brief centrifugation 1571-1572. (10 4 ϫ g) to remove the mucus, the supernatant was recovered for Armstrong, D.S., Grimwood, K., and Carlin, J.H.B. (1996) . Bronchoalantibacterial assays and ion measurements. Sodium and chloride veolar lavage or oropharyngeal cultures to identify lower respiratory concentrations in ASF were measured using ion-specific glass mipathogens in infants with cystic fibrosis. Pediatr. Pulmonol. 21, croelectrodes (Londonderry, NH) calibrated to prepared standards. 267-275. Antibacterial studies were performed as previously described (Harwig et al., 1994; Smith et al., 1996) . Single colonies of bacteria, P.
Bensch, K.W., Raida, M., Magert, H.-J., Schulz-Knappe, P., and Forssmann, W.-G. (1995). hBD-1: a novel ␤-defensin from human aeruginosa (ATCC# 39324), or a clinical isolate were inoculated into LB broth and cultured overnight at 37ЊC. An aliquot of this culture plasma. FEBS Lett. 368, 331-335.
